Kerstin Schutze
Hamburg, HH 20246, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Immune Ablation and Stem Cell Rescue in Two Pediatric Patients with Progressive Severe Chronic Graft-Versus-Host Disease.
Journal: International journal of molecular sciences
Published: October 28, 2022
MAP kinase activating death domain deficiency is a novel cause of impaired lymphocyte cytotoxicity.
Journal: Blood advances
Published: May 25, 2022
Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs).
Journal: Cells
Published: November 28, 2019
Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies.
Journal: Molecular cancer therapeutics
Published: August 02, 2018
CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells.
Journal: Frontiers in immunology
Published: July 30, 2018
Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38+ tumors in mouse models in vivo.
Journal: Scientific reports
Published: May 25, 2017
Long-term CD38 saturation by daratumumab interferes with diagnostic myeloma cell detection.
Journal: Haematologica
Published: May 20, 2017
Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved in vivo detection.
Journal: Contrast media & molecular imaging
Published: September 03, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026